Jeremy Slivnick to Humans
This is a "connection" page, showing publications Jeremy Slivnick has written about Humans.
Connection Strength
0.447
-
Perivascular Amyloid Deposition in Immunoglobulin Light Chain Cardiac Amyloidosis and Its Implications on Echocardiographic Cardiac Remodeling. J Am Soc Echocardiogr. 2024 Oct; 37(10):1010-1012.
Score: 0.031
-
Echocardiographic Detection of Regional Wall Motion Abnormalities Using Artificial Intelligence Compared to Human Readers. J Am Soc Echocardiogr. 2024 Jul; 37(7):655-663.
Score: 0.031
-
Preservation of Circumferential and Radial Left Ventricular Function as a Mitigating Mechanism for Impaired Longitudinal Strain in Early Cardiac Amyloidosis. J Am Soc Echocardiogr. 2023 12; 36(12):1290-1301.
Score: 0.029
-
Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Eur Heart J Cardiovasc Imaging. 2023 05 31; 24(6):829-837.
Score: 0.029
-
Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2023 08; 16(8):1121-1123.
Score: 0.029
-
Serum amyloidosis: a cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2023 03 21; 24(4):e59.
Score: 0.028
-
Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonance. PLoS One. 2022; 17(11):e0264454.
Score: 0.028
-
Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis. Open Heart. 2022 03; 9(1).
Score: 0.026
-
Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis. Int J Cardiovasc Imaging. 2021 Mar; 37(3):1043-1051.
Score: 0.024
-
Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2021 01; 14(1):302-304.
Score: 0.024
-
Personalized Approach to Cancer Treatment-Related Cardiomyopathy. Curr Heart Fail Rep. 2020 04; 17(2):43-55.
Score: 0.023
-
Hypertension and Heart Failure. Heart Fail Clin. 2019 Oct; 15(4):531-541.
Score: 0.022
-
Current Trends in Anticoagulation Bridging for Patients With Chronic Atrial Fibrillation on Warfarin Undergoing Endoscopy. Am J Cardiol. 2018 06 15; 121(12):1548-1551.
Score: 0.020
-
Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
Score: 0.008
-
Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol. 2024 Apr; 49(4):102417.
Score: 0.008
-
Noninvasive assessment of left ventricular end-diastolic pressure using machine learning-derived phasic left atrial strain. Eur Heart J Cardiovasc Imaging. 2023 Dec 21; 25(1):18-26.
Score: 0.008
-
Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following Radiotherapy. Int J Radiat Oncol Biol Phys. 2024 Jan 01; 118(1):124-136.
Score: 0.007
-
Normative values of the aortic valve area and Doppler measurements using two-dimensional transthoracic echocardiography: results from the Multicentre World Alliance of Societies of Echocardiography Study. Eur Heart J Cardiovasc Imaging. 2023 03 21; 24(4):415-423.
Score: 0.007
-
Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosis. Echocardiography. 2023 03; 40(3):188-195.
Score: 0.007
-
Multichamber Strain Predicts Atrial Fibrillation in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2023 02; 36(2):257-259.
Score: 0.007
-
Three-Dimensional Echocardiographic Deconstruction: Feasibility of Clinical Evaluation from Two-Dimensional Views Derived from a Three-Dimensional Data Set. J Am Soc Echocardiogr. 2022 10; 35(10):1009-1017.e2.
Score: 0.007
-
Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2022 08; 35(8):829-835.e1.
Score: 0.007
-
Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study. Sci Rep. 2022 01 07; 12(1):140.
Score: 0.007
-
Heart failure with recovered ejection fraction and the utility of defibrillator therapy: a review. ESC Heart Fail. 2022 02; 9(1):1-10.
Score: 0.007
-
Imaging-Based Risk Stratification for Recurrence Risk in Women with a History of Peripartum Cardiomyopathy. Am J Perinatol. 2022 02; 39(3):225-231.
Score: 0.007
-
Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis. J Am Heart Assoc. 2021 05 04; 10(9):e019840.
Score: 0.006
-
Contemporary Understandings of Cardiovascular Disease After Cancer Radiotherapy: a Focus on Ischemic Heart Disease. Curr Cardiol Rep. 2020 09 23; 22(11):151.
Score: 0.006
-
A Case for the Use of Transesophageal Echocardiography in the ED Treatment of Cardiac Arrest. Chest. 2020 05; 157(5):e173-e176.
Score: 0.006